Cytek Biosciences Inc
NASDAQ:CTKB
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
Cytek Biosciences Inc
NASDAQ:CTKB
|
782.3m USD | 80.5 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
218B USD | 27.1 | ||
US |
Danaher Corp
NYSE:DHR
|
190.9B USD | 28.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
43.5B USD | 22.6 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.1B USD | 23.3 | ||
CH |
Lonza Group AG
SIX:LONN
|
35.8B CHF | 26.5 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
53T KRW | 31.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31B USD | 32.9 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.6B USD | 22.6 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
23.8B USD | 31.1 | ||
US |
Waters Corp
NYSE:WAT
|
19.8B USD | 32.1 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.